Science
As competitors publicly entered the race to produce a vaccine, drug giant Merck stayed quiet about its development plans. Now, the company has revealed it’s working on two vaccines and a treatment pill -- emerging as a frontrunner in the development contest. Although the company has refused to give firm timelines for its research, it has pledged to make its vaccines and pill available globally, if they're successful. Riley Griffin talked with Merck Chief Executive Kenneth C. Frazier about the company's plans.
See omnystudio.com/listener for privacy information.
More Episodes
Breakthrough: The Future of mRNA
2021-12-07
2021-12-07
Breakthrough: The Vaccine Race
2021-11-30
2021-11-30
Breakthrough: Unlikely Heroes
2021-11-23
2021-11-23
Breakthrough: The Covid Fortress
2021-11-16
2021-11-16
Breakthrough: Covid’s Long, Scary Tail
2021-11-09
2021-11-09
Breakthrough: Rehab for Long Haulers
2021-11-02
2021-11-02
Breakthrough: Long Covid’s Early Origins
2021-10-19
2021-10-19
Introducing: Breakthrough
2021-10-06
2021-10-06
Doubt, Bonus: A Surprising Southern Success
2021-09-28
2021-09-28
Doubt: Hope
2021-04-20
2021-04-20
Doubt: Getting Out of the Boat
2021-04-13
2021-04-13
Doubt: 'Let's Go to War'
2021-04-06
2021-04-06
Doubt: The Happiest Place on Earth
2021-03-30
2021-03-30
Doubt: The Man Behind The Myth
2021-03-23
2021-03-23
Doubt: Rumor Has It
2021-03-23
2021-03-23
What Closing Schools Has Done to Kids
2021-03-15
2021-03-15
The Science of Beating Variants
2021-03-12
2021-03-12
Introducing: Doubt
2021-03-11
2021-03-11
One Year
2021-03-10
2021-03-10
Get this podcast on your
phone, FREE
